Skip to main content
Log in

Detection of SBEM-mRNA in peripheral blood of patients with breast cancer and its clinical significance

  • Published:
Chinese Journal of Cancer Research

Abstract

Objective

The aim of the present study is to explore the expression of a specific marker of breast cancer, small breast epithelial mucin (SBEM) mRNA, in peripheral blood and to investigate its significance.

Methods

The expressions of SBEM-mRNA in peripheral blood of 67 patients with breast cancer, 16 patients with benign breast disease, and 20 normal healthy volunteers were detected with nested reverse transcription-polymerase chain reaction (Nested-RT-PCR).

Results

SBEM-mRNA was negative in healthy individuals and patients with benign breast tumor, but 50.7%(34/67) of breast cancer patients showed positive expression of SBEM-mRNA in peripheral blood, of whom 25%(2/8) were in stage I, 45.8%(11/24) in stage II, 43.75%(11/24) in stage III and 73.7(14/19) in stage IV. The positive rate in stage IV was higher than that in stage I, II, III (P<0.05). Expressions of SBEM-mRNA had no correlation with age, carcinoma size, pathological type, ER and PR state (P<0.05).

Conclusion

SEBM-mRNA is specifically expressed in breast cancer and it may act as a marker for the detection of micrometastasis of breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bundred NJ. Prognostic and predictive factors in breast cancer[J]. Cancer Treat Rev 2001; 27:137–142.

    Article  PubMed  CAS  Google Scholar 

  2. Ghossein RA, Rosai J. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells[J]. Cancer 1996; 78: 10–16.

    Article  PubMed  CAS  Google Scholar 

  3. Fabisiewicz A, Kulik J, Kober P, et al. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay[J]. Acta Biochim Pol. 2004; 51:747–755.

    PubMed  CAS  Google Scholar 

  4. Kawakita M, Hiramatsu K, Sugimoto M, et al. Clinical usefulness of urinary diacetylpolyamines as novel tumor markers[J]. Rinsho Byori 2004; 52:321–327.

    PubMed  CAS  Google Scholar 

  5. Schuler GD. Pieces of the puzzle: expressed sequence tags and the catalog of human genes[J]. J Mol Med 1997; 75: 694–698.

    Article  PubMed  CAS  Google Scholar 

  6. Hatey F. Expressed sequence tags for genes: a review [J]. Genet Sel Evol 1998; 30: 512–541 and Serial Analysis of Gene expression—SAGE [Velculescu VE, Zhang L, Vogelstein B, et al. Serial analysis of gene expression[J]. Science 1995; 270: 484–7.

    Google Scholar 

  7. Miksicek RJ, Myal Y, Watson PH, et al. Identification of a novel breast-and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium[J]. Cancer Res 2002; 62: 2736–2740.

    PubMed  CAS  Google Scholar 

  8. YE Jing; SHAN Bao-en. Research on Breast Cancer Susceptibility Genes [J]. Chin J Cancer 2002; 21:1035–1039.

    Google Scholar 

  9. Berois N, Varangot M, Aizen B, et al. Molecular detection of cancer cells in bone marrow and peripheral blood of patients with operable breast cancer. Comparison of CK19, MUC1 and CEA using RT-PCR[J]. Eur J Cancer 2000; 36: 717–723.

    Article  PubMed  CAS  Google Scholar 

  10. Stathopoulou A, Mavroudis D, Perraki M, et al. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers[J]. Anticancer Res 2003; 23: 1883–1890.

    PubMed  CAS  Google Scholar 

  11. Roncella S, Ferro P, Bacigalupo B, et al. Human mammaglobin mRNA is a reliable molecular marker for detecting occult breast cancer cells in peripheral blood[J]. J Exp Clin Cancer Res 2005; 24: 265–271.

    PubMed  CAS  Google Scholar 

  12. Mori M, Mimori K, Ueo H, et al. Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease[J]. Int J Cancer 1996; 68: 739–743.

    Article  PubMed  CAS  Google Scholar 

  13. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation[J]. Cancer Res. 1991; 51(18 Suppl): 5054–5059.

    Google Scholar 

  14. Meric-Bernstam F. Breast conservation in breast cancer: surgical and adjuvant considerations[J]. Curr Opin Obstet Gynecol 2004; 16:31–36.

    Article  PubMed  Google Scholar 

  15. Gerber B, Scholz C, Reimer T, Briese V. et al. Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review[J]. Breast Cancer Res Treat 2005; 28:1–11.

    Google Scholar 

  16. Paik S, Shak S, Tang G, et al. Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer[J]. ASCO Annual Meeting, 2005.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yang Nan-Wu  (杨南武).

Additional information

Foundation item: This work was supported by the Natural Science Foundation of Guanxi Province (No. 0640161).

Biography: YANG Hua-wei (1973–), male, master of medicine, Guangxi Medical University, majors in surgical oncology.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yang, HW., Yang, NW., Cao, J. et al. Detection of SBEM-mRNA in peripheral blood of patients with breast cancer and its clinical significance. Chin. J. Cancer Res. 18, 294–298 (2006). https://doi.org/10.1007/s11670-006-0294-4

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11670-006-0294-4

Key Words

CLC number

Navigation